Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series.
J Clin Med Res
; 11(3): 219-224, 2019 Mar.
Article
in En
| MEDLINE
| ID: mdl-30834046
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Clin Med Res
Year:
2019
Document type:
Article
Affiliation country:
Japan
Country of publication:
Canada